Get started
MERCK & CO INCMERCK & CO INCMERCK & CO INC

MERCK & CO INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

6MK chart


Full chart

Key facts today

Merck's Keytruda is in a Phase 3 trial (EVOKE-03) with Gilead's Trodelvy for PD-L1-high Metastatic Non-small Cell Lung Cancer, starting February 2023 and expected to finish by January 2027.
Analyze the impactAnalyze the impact

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪241.21 B‬CHF
Dividend yield (indicated)
2.81%
Price to earnings Ratio (TTM)
20.578
Basic EPS (TTM)
4.872CHF
Net income (FY)
‪307.31 M‬CHF
Revenue (FY)
‪50.41 B‬CHF
Shares float
‪2.53 B‬
Beta (1Y)
0.36

Employees


Employees (FY)
‪72 K‬
Revenue / Employee (1Y)
‪831.54 K‬CHF
Net income / Employee (1Y)
‪5.07 K‬CHF

About Merck & Company, Inc.


Sector
Health Technology
CEO
Robert M. Davis
Headquarters
Rahway
Website
merck.com
Founded
1891
FIGI
BBG006TLRZM7
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


MRK.GF
Merck & Co., Inc. 5.76% 03-MAY-2037
US58933YBN4
MERCK & CO. 23/63
US58933YBM6
MERCK & CO. 23/53
US58933YBL8
MERCK & CO. 23/44
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049
MRK3675698
Merck & Co., Inc. 5.85% 30-JUN-2039
US58933YAT2
MERCK CO. 2045
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042
US58933YAJ4
MERCK CO. 13/43
MRK.GJ
Merck & Co., Inc. FRN 06-FEB-2041
US58933YAV7
MERCK & CO. 19/39

Explore more bonds 

Sparks


Curated watchlists where 6MK is featured.

See all sparks 

Frequently Asked Questions


The current price of 6MK is 94.802 CHF — it has decreased by −1.53% in the past 24 hours. Watch MERCK & CO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange MERCK & CO INC stocks are traded under the ticker 6MK.
6MK stock has fallen by −0.41% compared to the previous week, the month change is a −5.11% fall, over the last year MERCK & CO INC has showed a 0.90% increase.
We've gathered analysts' opinions on MERCK & CO INC future price: according to them, 6MK price has a max estimate of 134.20 CHF and a min estimate of 99.57 CHF. Watch 6MK chart and read a more detailed MERCK & CO INC stock forecast: see what analysts think of MERCK & CO INC and suggest that you do with its stocks.
6MK reached its all-time high on May 21, 2024 with the price of 120.163 CHF, and its all-time low was 66.306 CHF and was reached on Sep 15, 2021. View more price dynamics on 6MK chart.
See other stocks reaching their highest and lowest prices.
6MK stock is 1.55% volatile and has beta coefficient of 0.36. Track MERCK & CO INC stock price on the chart and check out the list of the most volatile stocks — is MERCK & CO INC there?
Today MERCK & CO INC has the market capitalization of ‪238.90 B‬, it has decreased by −2.09% over the last week.
Yes, you can track MERCK & CO INC financials in yearly and quarterly reports right on TradingView.
MERCK & CO INC is going to release the next earnings report on Oct 31, 2024. Keep track of upcoming events with our Earnings Calendar.
6MK earnings for the last quarter are 2.05 CHF per share, whereas the estimation was 1.95 CHF resulting in a 5.17% surprise. The estimated earnings for the next quarter are 1.30 CHF per share. See more details about MERCK & CO INC earnings.
MERCK & CO INC revenue for the last quarter amounts to ‪14.49 B‬ CHF, despite the estimated figure of ‪14.27 B‬ CHF. In the next quarter, revenue is expected to reach ‪13.93 B‬ CHF.
6MK net income for the last quarter is ‪4.90 B‬ CHF, while the quarter before that showed ‪4.30 B‬ CHF of net income which accounts for 14.16% change. Track more MERCK & CO INC financial stats to get the full picture.
Yes, 6MK dividends are paid quarterly. The last dividend per share was 0.65 CHF. As of today, Dividend Yield (TTM)% is 2.83%. Tracking MERCK & CO INC dividends might help you take more informed decisions.
MERCK & CO INC dividend yield was 2.72% in 2023, and payout ratio reached ‪2.07 K‬%. The year before the numbers were 2.52% and 49.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 19, 2024, the company has ‪72.00 K‬ employees. See our rating of the largest employees — is MERCK & CO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCK & CO INC EBITDA is ‪18.18 B‬ CHF, and current EBITDA margin is 11.45%. See more stats in MERCK & CO INC financial statements.
Like other stocks, 6MK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCK & CO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCK & CO INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCK & CO INC stock shows the sell signal. See more of MERCK & CO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.